TRxADE HEALTH (MEDS) Short Interest Ratio & Short Volume → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free MEDS Stock Alerts $5.91 -0.35 (-5.59%) (As of 02:38 PM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media TRxADE HEALTH Short Interest DataCurrent Short Volume20,500 sharesPrevious Short Volume34,000 sharesChange Vs. Previous Month-39.71%Dollar Volume Sold Short$149,650.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Outstanding Shares1,410,000 sharesFloat Size848,800 sharesShort Percent of Float2.42%Today's Trading Volume6,955 sharesAverage Trading Volume340,632 sharesToday's Volume Vs. Average2% Short Selling TRxADE HEALTH ? Sign up to receive the latest short interest report for TRxADE HEALTH and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMEDS Short Interest Over TimeMEDS Days to Cover Over TimeMEDS Percentage of Float Shorted Over Time Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. TRxADE HEALTH Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202420,500 shares $149,650.00 -39.7%2.4%0 $7.30 3/31/202434,000 shares $348,160.00 -39.3%4.0%0.1 $10.24 3/15/202456,000 shares $1.61 million +80.7%6.6%0.1 $28.80 2/29/202431,000 shares $295,120.00 +171.9%3.7%0.1 $9.52 2/15/202411,400 shares $51,072.00 -9.5%1.3%0.1 $4.48 1/31/202412,600 shares $52,542.00 -13.1%1.5%1.3 $4.17 Get the Latest News and Ratings for MEDS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. 1/15/202414,500 shares $70,760.00 +48.0%1.7%1.8 $4.88 12/31/20239,800 shares $50,923.74 -36.8%N/A0.9 $5.20 12/15/202315,500 shares $85,250.00 +12.3%1.7%1.3 $5.50 11/30/202313,800 shares $82,110.00 +32.7%1.5%0.7 $5.95 11/15/202310,400 shares $61,568.00 -12.6%1.2%0 $5.92 10/31/202311,900 shares $69,258.00 +38.4%1.3%0 $5.82 10/15/20238,600 shares $59,942.00 -30.1%1.0%0 $6.97 9/30/202312,300 shares $86,469.00 -12.1%1.4%0 $7.03 9/15/202314,000 shares $111,580.00 +125.8%1.6%0 $7.97 8/31/20236,200 shares $47,368.00 +1.6%1.0%0 $7.64 8/15/20236,100 shares $47,397.00 +10.9%1.0%0 $7.77 7/31/20235,500 shares $40,810.00 -63.1%1.4%0 $7.42 7/15/202314,900 shares $155,854.00 -88.4%4.5%0 $10.46 6/30/2023128,500 shares $1.68 million +1,377.0%38.5%0.3 $13.05 6/15/20238,700 shares $43,065.00 -90.6%2.6%0 $4.95 5/31/202392,900 shares $26,012.00 +1.6%1.9%0.2 $0.28 5/15/202391,400 shares $36,048.16 +140.5%1.9%0.6 $0.39 4/30/202338,000 shares $12,697.74 -45.7%0.8%0.2 $0.33 4/15/202370,000 shares $20,804.00 -6.8%1.3%0.3 $0.30 3/31/202375,100 shares $22,154.50 +39.9%1.5%0.2 $0.30 3/15/202353,700 shares $19,332.00 +13.8%1.2%0.1 $0.36 2/28/202347,200 shares $19,663.52 +76.1%1.0%0.1 $0.42 2/15/202326,800 shares $10,452.00 -68.2%0.6%0.1 $0.39 1/31/202384,200 shares $35,380.84 -36.0%1.8%0.2 $0.42 1/15/2023131,500 shares $53,310.10 +73.0%2.8%0.6 $0.41 12/30/202276,000 shares $30,597.60 -31.9%1.6%0.4 $0.40 12/15/2022111,600 shares $55,253.16 +12.6%2.3%4.4 $0.50 11/30/202299,100 shares $55,991.50 +3.1%2.1%0.2 $0.57 11/15/202296,100 shares $68,970.97 +14.3%2.0%0.2 $0.72 10/31/202284,100 shares $74,849.00 -10.7%2.0%0.2 $0.89 10/15/202294,200 shares $85,486.50 -36.5%2.7%0.2 $0.91 9/30/2022148,400 shares $167,692.00 +108.4%4.2%0.3 $1.13 9/15/202271,200 shares $82,592.00 -59.6%2.3%0.1 $1.16 8/31/2022176,300 shares $204,508.00 +195.8%5.3%3.1 $1.16Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. MEDS Short Interest - Frequently Asked Questions What is TRxADE HEALTH's current short interest? Short interest is the volume of TRxADE HEALTH shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 20,500 shares of MEDS short. 2.42% of TRxADE HEALTH's shares are currently sold short. Learn More on TRxADE HEALTH's current short interest. What is a good short interest percentage for TRxADE HEALTH? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.42% of TRxADE HEALTH's floating shares are currently sold short. Is TRxADE HEALTH's short interest increasing or decreasing? TRxADE HEALTH saw a drop in short interest in April. As of April 15th, there was short interest totaling 20,500 shares, a drop of 39.7% from the previous total of 34,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TRxADE HEALTH's float size? TRxADE HEALTH currently has issued a total of 1,410,000 shares. Some of TRxADE HEALTH's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TRxADE HEALTH currently has a public float of 848,800 shares. How does TRxADE HEALTH's short interest compare to its competitors? 2.42% of TRxADE HEALTH's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to TRxADE HEALTH: Cosmos Health Inc. (2.93%), BIMI Holdings Inc. (0.76%), Vapotherm, Inc. (9.92%), Intelligent Bio Solutions Inc. (2.61%), Lixte Biotechnology Holdings, Inc. (4.59%), OpGen, Inc. (1.36%), ASLAN Pharmaceuticals Limited (1.47%), IM Cannabis Corp. (3.67%), Biofrontera Inc. (1.20%), TFF Pharmaceuticals, Inc. (2.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short TRxADE HEALTH stock? Short selling MEDS is an investing strategy that aims to generate trading profit from TRxADE HEALTH as its price is falling. MEDS shares are trading down $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TRxADE HEALTH? A short squeeze for TRxADE HEALTH occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDS, which in turn drives the price of the stock up even further. How often is TRxADE HEALTH's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Cosmos Health Short Squeeze BIMI Short Squeeze Vapotherm Short Squeeze Intelligent Bio Solutions Short Squeeze Lixte Biotechnology Short Squeeze OpGen Short Squeeze ASLAN Pharmaceuticals Short Squeeze IM Cannabis Short Squeeze Biofrontera Short Squeeze TFF Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MEDS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets